IQV

SEC source: 0001209191-16-145004 · doc4.xml · derivative · entry 4

Knightly Kevin C · CIK 0001350000 · Pres Info & Tech Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,040

Underlying: Common Stock · 23,040 shares

Expires 2020-03-15

F5 · price: Received in the Merger in exchange for a stock option to acquire 60,000 shares of IMS Health common stock for $3.20 per share.

SEC source: 0001209191-16-145004 · doc4.xml · derivative · entry 3

Knightly Kevin C · CIK 0001350000 · Pres Info & Tech Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,040

Underlying: Common Stock · 23,040 shares

Expires 2020-03-15

F4 · price: Received in the Merger in exchange for a stock option to acquire 60,000 shares of IMS Health common stock for $5.80 per share.

SEC source: 0001209191-16-145004 · doc4.xml · derivative · entry 2

Knightly Kevin C · CIK 0001350000 · Pres Info & Tech Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,080

Underlying: Common Stock · 46,080 shares

Expires 2020-03-15

F3 · price: Received in the Merger in exchange for a stock option to acquire 120,000 shares of IMS Health common stock for $10.00 per share.

SEC source: 0001209191-16-145004 · doc4.xml · nonDerivative · entry 1

Knightly Kevin C · CIK 0001350000 · Pres Info & Tech Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,826

F1 · price: On May 3, 2016, Quintiles Transnational Holdings Inc. ("Quintiles") and IMS Health Holdings, Inc. ("IMS Health") entered into an Agreement and Plan of Merger pursuant to which, on October 3, 2016, IMS Health merged with and into Quintiles (the "Merger"), the separate existence of IMS Health ceased and Quintiles continued as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. ("Quintiles IMS Holdings"). The exchange ratio in the Merger was 0.3840 shares of Quintiles common stock for each share of IMS Health common stock. On the effective date of the Merger, the market value of Quintiles' common stock was $81.06 per share, and the market value of IMS Health's common stock was $31.34 per share.

F2 · price: Received in exchange for 69,866 shares of IMS Health common stock, restricted stock and restricted stock units in connection with the Merger.

SEC source: 0001209191-16-144998 · doc4.xml · derivative · entry 9

BOUSBIB ARI · CIK 0001184180 · Director · Chairman, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,592

Underlying: Common Stock · 127,592 shares

Expires 2026-02-02

F13 · price: Received in the Merger in exchange for a stock appreciation right to acquire 332,272 shares of IMS Health common stock for $23.00 per share.

F12 · derivative.exercise_date: This stock appreciation right vests in four annual installments beginning on February 2, 2017.

SEC source: 0001209191-16-144998 · doc4.xml · derivative · entry 8

BOUSBIB ARI · CIK 0001184180 · Director · Chairman, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,847

Underlying: Common Stock · 82,847 shares

Expires 2025-02-10

F11 · price: Received in the Merger in exchange for a stock appreciation right to acquire 215,749 shares of IMS Health common stock for $25.02 per share.

F10 · derivative.exercise_date: This stock appreciation right vests in four annual installments, with the first installment having vested on February 10, 2016 and the remaining three installments vesting on February 10, 2017, 2018 and 2019.

SEC source: 0001209191-16-144998 · doc4.xml · derivative · entry 7

BOUSBIB ARI · CIK 0001184180 · Director · Chairman, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 460,800

Underlying: Common Stock · 460,800 shares

Expires 2020-12-01

F9 · price: Received in the Merger in exchange for a stock option to acquire 1,200,000 shares of IMS Health common stock for $3.20 per share.

SEC source: 0001209191-16-144998 · doc4.xml · derivative · entry 6

BOUSBIB ARI · CIK 0001184180 · Director · Chairman, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 230,400

Underlying: Common Stock · 230,400 shares

Expires 2020-12-01

F8 · price: Received in the Merger in exchange for a stock option to acquire 600,000 shares of IMS Health common stock for $5.80 per share.

SEC source: 0001209191-16-144998 · doc4.xml · derivative · entry 5

BOUSBIB ARI · CIK 0001184180 · Director · Chairman, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 460,800

Underlying: Common Stock · 460,800 shares

Expires 2020-12-01

F7 · price: Received in the Merger in exchange for a stock option to acquire 1,200,000 shares of IMS Health common stock for $10.00 per share.

SEC source: 0001209191-16-144998 · doc4.xml · derivative · entry 4

BOUSBIB ARI · CIK 0001184180 · Director · Chairman, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,000

Underlying: Common Stock · 192,000 shares

Expires 2020-12-01

F6 · price: Received in the Merger in exchange for a stock option to acquire 500,000 shares of IMS Health common stock for $8.20 per share.

SEC source: 0001209191-16-144998 · doc4.xml · derivative · entry 3

BOUSBIB ARI · CIK 0001184180 · Director · Chairman, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,000

Underlying: Common Stock · 192,000 shares

Expires 2020-12-01

F5 · price: Received in the Merger in exchange for a stock option to acquire 500,000 shares of IMS Health common stock for $10.80 per share.

SEC source: 0001209191-16-144998 · doc4.xml · nonDerivative · entry 2

BOUSBIB ARI · CIK 0001184180 · Director · Chairman, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 543,302

F1 · price: On May 3, 2016, Quintiles Transnational Holdings Inc. ("Quintiles") and IMS Health Holdings, Inc. ("IMS Health") entered into an Agreement and Plan of Merger pursuant to which, on October 3, 2016, IMS Health merged with and into Quintiles (the "Merger"), the separate existence of IMS Health ceased and Quintiles continued as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. ("Quintiles IMS Holdings"). The exchange ratio in the Merger was 0.3840 shares of Quintiles common stock for each share of IMS Health common stock. On the effective date of the Merger, the market value of Quintiles' common stock was $81.06 per share, and the market value of IMS Health's common stock was $31.34 per share.

F3 · price: Received in exchange for 1,414,850 shares of IMS Health common stock in connection with the Merger.

F4 · ownership.nature: Shares held in Orohena Trust.

SEC source: 0001209191-16-144998 · doc4.xml · nonDerivative · entry 1

BOUSBIB ARI · CIK 0001184180 · Director · Chairman, CEO & Pres

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 736,177

F1 · price: On May 3, 2016, Quintiles Transnational Holdings Inc. ("Quintiles") and IMS Health Holdings, Inc. ("IMS Health") entered into an Agreement and Plan of Merger pursuant to which, on October 3, 2016, IMS Health merged with and into Quintiles (the "Merger"), the separate existence of IMS Health ceased and Quintiles continued as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. ("Quintiles IMS Holdings"). The exchange ratio in the Merger was 0.3840 shares of Quintiles common stock for each share of IMS Health common stock. On the effective date of the Merger, the market value of Quintiles' common stock was $81.06 per share, and the market value of IMS Health's common stock was $31.34 per share.

F2 · price: Received in exchange for 1,917,133 shares of IMS Health common stock and restricted stock units in connection with the Merger.

SEC source: 0001209191-16-144322 · doc4.xml · nonDerivative · entry 1

Pike Thomas · CIK 0001471570 · Director · Vice Chair, Pres R&D Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,936

F1 · security: Grant to the reporting person of restricted stock under the Quintiles IMS Holdings, Inc. 2013 Stock Incentive Plan (f/k/a the Quintiles Transnational Holdings Inc. 2013 Stock Incentive Plan) (the "Plan"). The restricted stock will vest in three equal installments on June 30, 2017, September 30, 2017 and December 31, 2017.

F2 · balance_after: This amount includes 86,356 shares of restricted stock granted on September 30, 2016.